For details on already scheduled symposia and the respective chairpersons "click here"
Dear Termis participants,
below you will find the TERMIS scientific programme listed by day and time. Click on a day and proceed to a particular time and see the individual symposia. The term "sessions" refers to the scientific sessions, which will take place at a particular time. For complete programme, click on “download”.
Wed, September 5, 2012
| Time | Activity |
|---|
| 15:00 - 17:00 | 2 Sessions| Room | Title |
|---|
| Forum | 76 Special Technology Session| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 76.01 | Engineering hydrophobin DewA to generate surface coatings that enhance adhesion of human but not bacterial cells | 10 | | 76.02 | Porous titanium as a high-strength scaffold for bone tissue engineering | 10 | | 76.03 | Performance characterization and initial clinical experience using a filter-based, single-use, disposable system for procuring progenitor cells from peripheral blood | 10 | | 76.04 | Lipogems ®: new device, method and human fat tissue product highly enriched in mesenchymal stem cells ready for autologous cell therapy and regenerative medicine | 10 | | 76.05 | Virusinactivation capacity of CTBA cleaning process | 10 | | 76.07 | Synergetic Cell Population – a powerful tool for autologous therapies | 10 | | 76.08 | Avoid pitfalls in your adoption of 3D cell culture | 10 |
| | Gartensaal | 73 Education in Term (in coop. Expertissues)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 73.01 | Keynote: The European perspective: short courses in the EC FP7 \"EXPERTISSUES\" network of excellence | 20 | | 73.02 | Keynote: Industry perspectives on education & training needs | 20 | | 73.03 | Keynote: Challenges in tissue engineering education: South-East Asian perspectiv | 20 | | 73.04 | Keynote: Undergraduate research experiences and career trajectories | 20 | | 73.05 | Keynote: Experiences of leading a taught MSc in cell & tissue engineering | 20 | | 73.06 | Keynote: A practical approach for developing an undergraduate tissue engineering laboratory class | 20 |
|
|
| 17:00 - 18:30 | Poster Session & Welcome in Austria Break |
| 18:30 - 19:30 | Ground Floor Foyer: Student Mentor Meet |
Thu, September 6, 2012
| Time | Activity |
|---|
| 08:30 - 09:00 | Plenary Lecture (Festsaal) - Human disease models through tissue engineering, David Kaplan |
| 09:00 - 10:30 | 6 Sessions| Room | Title |
|---|
| Festsaal | 42 Adipose-derived Cells for Regenerative Medicine: Pre-Clinical Overview (in coop. IFATS)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 42.01 | Keynote: Regenerative properties of adipose derived stroma cells and aging | 25 | | 42.02 | Keynote: Effect of burn injury on mesenchymal stem cell niches: the mechanism behind hetertopic ossification | 20 | | 42.03 | Primary cilia: does cilium architecture predict lineage specification in adipose-derived stem cells | 10 | | 42.04 | Human platelet lysate favours stemness of adipose derived stem cells | 10 | | 42.05 | A nerve repair conduit containing differentiated adipose-derived stem cells within engineered neural tissue can support and guide neuronal growth in vitro and in vivo | 10 |
| | Zeremoniensaal | 03 Tissue Engineering from Lab via Translation to Clinical Application (TERMIS thematic group) (in coop. Bone-Tec)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 03.01 | Keynote: Signals in biomaterial constructs to improve bone vascularization | 15 | | 03.02 | Keynote: Exploring and engineering the cell-material interface for regenerative medicine | 15 | | 03.04 | Keynote: Strategies for vascularised bone tissue engineering: combining honeycombed-like scaffolds, biaxial bioreactor, growth factors, co-culture of stem cells | 15 | | 03.05 | Keynote: Bone engineering from in vivo to clinical application | 15 | | 03.06 | Keynote: Bone development towards artificial surfaces | 15 |
| | Forum | 57 TE for in Vitro Tests| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 57.01 | Keynote: Incorporating microfabricated models of gastrointestinal tract into “Body-on-a-Chip” devices | 30 | | 57.02 | Digital microfabrication of tissue arrays for pharmaceutical investigations | 15 | | 57.03 | Engineering a functional in vitro model of the spinal stretch reflex arc | 15 | | 57.04 | Thymus engineering: 3D in vitro model to culture functional adult thymic epithelial cells | 15 | | 57.05 | 3D bioengineered model of the tumor-stroma microenvironment of late stage ovarian cancer | 15 |
| | Rittersaal | 46 From Cells to Secretomes in Regenerative Medicine| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 46.02 | Keynote: Mesenchymal stem cell derived secretomes: cardiac regeneration and cytoprotection in vitro and vivo | 15 | | 46.03 | Keynote: Mesenchymal stem cells as “medicinal” cells: induction of endogenous bone repair | 15 | | 46.04 | Using the secretome of mesenchymal progenitors of the umbilical cord as a modulator of neural and glial survival, viability and differentiation | 10 | | 46.05 | Human placenta mesenchymal cells after intravenous transplantation into rats with experimental ischemic stroke undergo homing in brain neurogenic zones and enhance neurogenesis | 10 |
| | Gartensaal | 53 Micro- and Nano-Tomographic Imaging in TERM| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 53.01 | Keynote: In vivo monitoring of vascular development and regeneration | 25 | | 53.02 | Use of innovative techniques based on X-ray synchrotron radiation in advanced regenerative orthodontics | 8 | | 53.03 | Imaging hydrogel-based engineered tissues with a benchtop X-ray imager | 8 | | 53.04 | X-ray absorption and X-ray diffraction microtomography of biodegradable polymer based composites | 8 | | 53.05 | Keynote: Multi-mode imaging of bone and fracture callus | 25 |
| | Geheime Ratstube | 63 Extracorporeal Shock Wave Therapy - a New Means in Regenerative Medicine?| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 63.01 | Keynote: Extracorporeal shockwave therapy (ESWT) – from bench to bedside | 15 | | 63.02 | Extracorporeal shock waves – a novel method of mechanostimulation in tissue regeneration | 8 | | 63.03 | Unfocused extracorporeal shock waves induce anabolic responses in osteoporotic bone | 8 | | 63.04 | Myocardial regeneration by low energy shock wave treatment | 8 | | 63.05 | Extracorporal shock wave therapy (ESWT) in ischemic challenged tissue | 8 | | 63.06 | Extracorporeal shockwave treatment induced extracellular ATP release – a potential mechanism to activate wound healing | 8 | | 63.07 | Shockwaves induce stem cell differentiation through ATP release and P2X7 receptor activation | 8 |
|
|
| 10:30 - 11:00 | Coffee Break |
| 11:00 - 12:30 | 6 Sessions| Room | Title |
|---|
| Festsaal | 43 Adipose-derived Cells for Regenerative Medicine: Clinical Overview (in coop. IFATS)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 43.02 | Keynote: Therapeutic applications of adipose tissue and its progenitor cells | 20 | | 43.03 | Keynote: A phase I clinical trial for maxillary bone augmentation with adipose stem cells and calcium phosphte scaffolds | 15 | | 43.04 | Differentiation of adipose-derived mesenchymal cells to endocrine pancreatic lineage | 10 | | 43.05 | Safety and efficacy of adipose engineered tissue in breast reconstruction a translational experience | 10 |
| | Zeremoniensaal | 64 Biofabrication - Platforms for 3D high throughput screening and cell culture| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 64.02 | High throughput stem cell differentiation | 10 | | 64.03 | In vivo screening of cells in three dimensions enables the discovery of a novel cartilage treatment | 10 | | 64.04 | Melt electrospinning in a direct writing mode | 10 | | 64.05 | Fabrication and assembling of hydrogel fibers into 3D bunchy constructs for engineering cardiac tissue | 10 | | 64.06 | Development of a manufacturing system for cell sheet production | 10 |
| | Forum | 65 Biomechanics and Modelling of Engineered Musculoskeletal Tissues (in coop. ESB (The European Society of Biomechanics))| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 65.01 | Keynote: Biomechanics of meniscal replacement | 15 | | 65.02 | Keynote: Multiscale mechanics and mechano-biology for bone and bone tissue engineering | 15 | | 65.03 | Simulation of the effect of mechanics on cell viability during degeneration of the Intervertebral Disc | 10 | | 65.04 | Non-label morphology-based detection of accumulated irregularity in cultured cells | 10 | | 65.05 | Fluid and mass transport modelling to drive the design of cell-packed hollow fibre bioreactors | 10 |
| | Rittersaal | 26 Collagen Technologies| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 26.02 | An optimised microgel for maintaining 3D viable microenvironment for human mesenchymal stem cells | 10 | | 26.03 | Cold gas plasma treatment for collagen films to modulate of inflammation | 10 | | 26.04 | Pilot production of novel recombinant bacterial collagens for use as tissue engineering scaffolds | 10 | | 26.05 | Structure and in vivo integration of dense collagen matrices | 10 | | 26.06 | Comparison of two gelatin and thrombin combination hemostats | 10 |
| | Gartensaal | 52 Optical and MRI Imaging in vivo (in coop. EIBIR)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 52.01 | Keynote: Imaging challenges in tissue engineering | 25 | | 52.02 | Keynote: Molecular MRI of the joint | 25 | | 52.03 | Diffusion tensor imaging to assess collagen structure in cardiovascular bioengineered tissues | 10 | | 52.04 | The use of fluorescent imaging to detect the neovascularization and differentiation of skeletal muscle in vivo. | 10 |
| | Geheime Ratstube | 24 Current Clinical Applications in Veterinary Medicine (in coop.IVRMS)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 24.01 | Keynote: Regenerative veterinary medicine – an overview | 15 | | 24.02 | Keynote: Experimental and clinical application of BMSCs for the treatment of large bone defects in animals | 15 | | 24.03 | Tracking of mesenchymal stem cells in tendon injuries following in vivo administration | 10 | | 24.04 | Serum increases the adhesion of bone marrow derived MSC to articular cartilage in vitro | 10 | | 24.05 | Tissue engineering for cartilage repair: in vitro development of an osteochondral scaffold | 10 |
|
|
| 12:30 - 13:00 | Lunch Break |
| 13:00 - 14:00 | Poster Session & Coffee & Cake |
| 14:00 - 15:30 | 6 Sessions| Room | Title |
|---|
| Festsaal | 32 Biomaterials for Regenerative Medicine (in coop. ESB)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 32.02 | Keynote: Self-assembling bioactive polymer systems for tissue engineering. Modulation of angiogenesis | 15 | | 32.03 | Biomaterials technology of regenerative medicine for patients | 10 | | 32.04 | Osteopromotive scaffolds for bone tissue engineering: a solvent-free manufacturing process based on extrusion and supercritical fluid processing | 10 | | 32.05 | Sugar-responsive water-solubilization of bone morphogenetic protein-2-incorporating gelatin hydrogel microspheres in cell aggregates | 10 | | 32.06 | Keynote: Structural impact of textile based implants for regenerative medicine | 15 |
| | Zeremoniensaal | 45 Targeting the Stem Cell Niche for Tissue Engineering| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 45.01 | Keynote: Deconstructing and reconstructing stem cell niches | 15 | | 45.02 | Keynote: Engineering homing and differentiation of mesenchymal progenitor cells during bone healing | 15 | | 45.03 | VEGF induced CXCL12/CXCR4 axis in the recruitment of mesenchymal stem cells (MSCs) by osteogenic differentiated bone marrow stromal cells (O-BMSCs) | 10 | | 45.04 | Mesenchymal Stem Cells (MSC) induce the homing of endogenous stem/progenitor cells through the activation of alternatively activated macrophages in an ectopic bone formation model | 10 | | 45.05 | Building bone marrow: engineering biophysical regulation of hematopoietic stem cell fate decisions | 10 |
| | Forum | 66 Animal Models for Preclinicals and Clinical Translation| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 66.01 | Keynote: Animal models for translational research | 25 | | 66.02 | A \"sensate\" surface replacement scaffold can monitor loading during cartilage regeneration | 10 | | 66.03 | Pre-treatment by mesenchymal stromal cells in rat kidney transplantation induces adverse immune responses | 10 | | 66.04 | Treatment of congenital birth defects in sheep using tissue engineering: 10 years single institute experience | 10 | | 66.05 | In-vivo osteoinductivity assays for bone grafting materials | 10 |
| | Rittersaal | 29 Natural Derived Polysaccharides (in coop. Expertissues)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 29.01 | Keynote: Polysacharide based scaffolds for an all range of regenerative medicine approches | 25 | | 29.02 | Porous polysaccharide-based scaffolds for human endothelial progenitor cells | 10 | | 29.03 | Physically cross-linked injectable chitosan-derived microgels as a template for cell delivery | 10 | | 29.04 | Learning from the cell-matrix crosstalk to improve a cell delivery system based on RGD-modified alginate | 10 | | 29.05 | Gellan gum-based bilayered scaffolds for application in osteochondral tissue engineering | 10 |
| | Gartensaal | 67 Orthopaedic Area (in coop. EORS)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 67.01 | Keynote: From imaging technologies to smart biomaterials and tissue engineering: novel concepts for bone regeneration | 15 | | 67.02 | Keynote: Convergence of delayed allogenic cell injection in a scaffold-based bone engineering therapy concept | 15 | | 67.03 | Reamer Irrigator Aspirate (RIA) putty for engineering craniofacial bone grafts | 10 | | 67.04 | Cell therapy without exogenous stem cells: insights from human experiments using serum-augmented bone grafts | 10 | | 67.05 | Functionalized biphasic silk scaffold for anterior cruciate ligament regeneration and bone tunnel healing in the porcine model | 10 |
| | Geheime Ratstube | 20 Trachea/Oesophagus/Chest - Repair and Replacement| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 20.01 | Determining the in vitro and in vivo immune response towards decellularized porcine tracheal allografts for airway transplantation | 10 | | 20.02 | The efficiency of stratified epithelial cell sheet fabrication by the addition of IL-1 receptor antagonist | 10 | | 20.03 | Isolation of CD34+ epithelial stem cells and decellularized oesophageal scaffolds holds potential for the production of a tissue-engineered oesophagus | 10 | | 20.04 | Esophageal reconstruction in six patients: a regenerative medicine approach | 10 | | 20.05 | Keynote: Tissue engineering – from bench to bedside and back to bench | 25 |
|
|
| 15:30 - 16:00 | Coffee Break |
| 17:30 - 18:00 | Opening (Festsaal) |
| 18:00 - 18:30 | Special Lecture (Festsaal) - Essentia et accendentia: The ecolution of understanding aetiology and therapy of diseases, Christian Noe |
| 18:30 - 20:00 | Get Together at Hofburg |
| 20:30 - 23:00 | Leopold Cafe: SYIS Night |
Fri, September 7, 2012
| Time | Activity |
|---|
| 08:30 - 09:00 | Plenary Lecture (Festsaal) - Overcoming problems of iPS based cell therapy: Japanese national project: Shinichi Nishikawa |
| 09:00 - 10:30 | 6 Sessions| Room | Title |
|---|
| Festsaal | 02 Bone Regeneration: Current and Future Strategies| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 02.01 | Keynote: Bone regeneration perspectives: employ mechano-biological principles to foster endogenous regeneration | 25 | | 02.02 | Enhanced attraction of M1, M2 macrophages and endothelial cells into mesenchymal stem cell - seeded fibrin hydrogels transplanted in a rat long bone fracture gap. | 10 | | 02.03 | A Platelet Rich Plasma (PRP) based membrane as a periosteal substitute with enhanced osteogenic and angiogenic properties for bone engineering | 10 | | 02.04 | Concentration and selection of osteogenic progenitors using magnetic labeling based on hyaluronan expression for immediate transplantation into a canine femoral multidefect model | 10 | | 02.05 | Platelet rich plasma-mediated delivery of BMP-7 for segmental bone defect regeneration | 10 |
| | Zeremoniensaal | 50 Preformed Vasculature and Induced Angiogenesis| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 50.01 | Keynote: Angiogenesis and tissue engineering – from isolated endothelial cells to preformed vasculature and surgical angiogenesis | 25 | | 50.02 | Role of heme oxygenase-1 in regenerative medicine | 10 | | 50.03 | VEGF expression by human mesenchymal stem cells promotes vascularization of osteogenic grafts, but shifts bone homeostasis towards increased resorption | 10 | | 50.04 | Recellularization of decellularized human placental vascular scaffolds for bioengineering | 10 | | 50.05 | In vivo fabrication of a vascular bed suitable for grafting cell sheets | 10 |
| | Forum | 75.1 Commercialization of Regenerative Products: The Academe/Industry Partnership| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 75.1.01 | Commercialization of regenerative medicine products: the academia-industry partnership | 0 | | 75.1.02 | Commercializing regenerative medicine therapeutics and sustaining a successful business | 0 | | 75.1.03 | Translating academic concepts to commercial medical products: A complex academic/industrial partnership | 0 | | 75.1.04 | Commercializing T cell immunotherapies | 0 | | 75.1.05 | Successful translation of academic research using combinations of mesenchymal stromal cells with pharmaceutical agents for clinical applications in regenerative medicine | 0 |
| | Rittersaal | 30 Hyaluronan and its Use in Tissue Engineering (in coop. Biodesign)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 30.01 | Keynote: Safe and efficient n-vivo gene gene transfer and silencing technologies using natural pathways | 25 | | 30.03 | Novel hyaluronic acid hydrogels for spinal cord repair | 10 | | 30.04 | Thiol-ene clickable PEG based thermoresponsive hyperbranched copolymer for in situ crosslinking hybrid hydrogel | 10 | | 30.05 | The release of rhBMP-2 from a bisphosphonate hydrogel | 10 | | 44.04 | Cross-linked hyaluronic acid as a scaffold for the treatment of cartilage defects | 10 |
| | Gartensaal | 48 Gene Transfer Approaches in Tissue Engineering| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 48.01 | Keynote: Combinatorial development of biomaterials and synthetic siRNA delivery systems | 20 | | 48.02 | Keynote: Ultrasound-mediated gene delivery: Potential and current limitations | 20 | | 48.03 | A simple and efficient 3D cyclised “Knot” polymer structure for nonviral gene delivery | 10 | | 48.04 | Non-viral sonoporation gene therapy for orthotopic bone regeneration | 10 | | 48.05 | Efficacy of TissueGene-C (TG-C), a cell mediated gene therapy, in patients with osteoarthritis: A phase IIa clinical study | 10 |
| | Geheime Ratstube | 41 Many Roads to iPS| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 41.01 | Keynote: Potential uses of iPS cell technology for treating and modeling human disease | 15 | | 41.02 | Non-invasive generation of human induced pluripotent stem cells from urine | 10 | | 41.03 | Cardiomyocyte-derived iPS cells supported by hydrogel possess an enhanced capacity to repair the damaged myocardium | 10 | | 41.04 | Proliferation and initial differentiation of mouse iPS cells in various-types of alginate hydrogel microcapsules | 10 | | 41.05 | Engineering the 3D morphogenic environment of pluripotent stem cells for directed differentiation | 10 | | 41.06 | Neural differentiation by human pluripotent stem cells is regulated by scaffold presentation | 10 |
|
|
| 10:30 - 11:00 | Coffee Break |
| 11:00 - 12:30 | 6 Sessions| Room | Title |
|---|
| Festsaal | 27 Extracellular Matrix and Cells from Natural Tissues (in coop. IPLASS)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 27.01 | Keynote: Hepatic cell-human amniotic epithelial cell (hAEC) interactions leading to ECM degradation | 25 | | 27.02 | Mimicking the properties of fetal cardiac extracellular matrix to stimulate cardiomyocyte proliferation | 15 | | 27.03 | Decellularised bone gels – novel materials for bone regeneration | 15 | | 27.04 | Catheter deliverable extracellular matrix derived hydrogel for treating myocardial infarction | 15 |
| | Zeremoniensaal | 51 Cocultures as Tools for Angiogenesis| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 51.01 | Keynote: Vessel network assembly within 3D tissues and its integration with functional vasculature | 25 | | 51.02 | Construction of functional ex-vivo liver tissues with pericyte-incorporated microvessels using microporous membranes | 10 | | 51.03 | Adipose-derived stem cells induce vascular tube formation of outgrowth endothelial cells in a fibrin matrix | 10 | | 51.04 | Delaying the addition of human mesenchymal stem cells to pre-formed endothelial cell networks results in increased vascularisation within a collagen-GAG scaffold in vivo | 10 | | 51.05 | The role of endogenous myeloid cells in cocultures of outgrowth endothelial cells and osteogenic cells in the formation of vascular structures | 10 |
| | Forum | 75.2 The Regulatory Imperative: International Perspective| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 75.2.01 | Lecture on the US regulatory environment of regenerative medicine | 0 | | 75.2.02 | Characterisation of cells for ATMPs | 0 | | 75.2.03 | Regulatory clarity to maximize the success of advanced therapies | 0 | | 75.2.04 | Regulatory experiences learned in the clinical development of MultiStem | 0 |
| | Rittersaal | 47 Mechanism on Stem Cell Action (in coop. REMEDIC)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 47.01 | Keynote: Progenitor and non-progenitor functions of MSCs: mechanisms and contexts | 25 | | 47.02 | Keynote: Skeletal tissue engineering: development of combination products | 25 | | 47.03 | Keynote: Immunomodulation by mesenchymal stem cells | 25 |
| | Gartensaal | 49 Genetransfer Approaches in Tissue Engineering II and gene activated matrices| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 49.01 | Keynote: Healing bones with gene activated matrices and other genetic strategies | 25 | | 49.02 | Controlling drug release spatially and temporally in scaffolds | 10 | | 49.03 | Development of a gene-activated matrix for enhanced bone tissue regeneration combining dual angiogenic and osteogenic non-viral gene delivery | 10 | | 49.04 | Gene silencing of chordin in combination with supplementation of BMP-2 has positive effects on osteogenic differentiation of human adipose tissue derived stem cells (hADSC) | 10 | | 49.05 | Fibrin mediated proangiogenic and secretory control gene therapy for compromised wound healing | 10 |
| | Geheime Ratstube | 01 Dental Field & Maxillofacial Area| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 01.01 | Keynote: The role of cell-cell communication for the transition from inflammation to bone regeneration | 20 | | 01.02 | Keynote: Influence of cellular inflammatory response on integration and vascularization of synthetic bone substitute materials | 20 | | 01.03 | Poly (L-lactic acid) nano-structured microspheres for dental tissue engineering | 10 | | 01.04 | Research and development of implant-type tissue-engineered cartilage clinically applied for the nasal correction of the cleft lip and palate patients | 10 | | 01.05 | Craniofacial osseous critical size defect regeneration is mediated by neural crest specific regulation of BMP-2-signalling | 10 |
|
|
| 12:30 - 13:00 | Lunch Break |
| 13:00 - 14:00 | Poster Session & Coffee & Cake |
| 14:00 - 15:30 | 6 Sessions| Room | Title |
|---|
| Festsaal | 06 Tissue engineering of functional tendons and ligaments| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 06.01 | Keynote: Translation for tendon engineering: efficacy, safety and standardization | 15 | | 06.02 | The blood-tendon barrier: A new jigsaw piece for understanding the tendon niche? | 10 | | 06.03 | Mechanostimulation of human mesenchymal stem cells in PHBHHx/collagen hybrid scaffolds for tendon tissue engineering applications | 10 | | 06.05 | Effects of BMP-2 eluting biphasic silk scaffold on ligament regeneration and bone tunnel healing in rabbits | 10 | | 06.06 | In vivo tendon engineering using skeletal muscle derived cells | 10 | | 31.P29 | The in vitro micro-environment interface: macromolecular crowding meets cell-sheet tissue engineering | 0 |
| | Zeremoniensaal | 40 Embryonic Stem Cells in TERM| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 40.01 | Keynote: Generation of skeletal hard tissues from pluripotent stem cells | 25 | | 40.02 | Human tendon perivascular cells are multipotent and express embryonic stem cell associated markers | 10 | | 40.03 | Spatial and temporal regulation of signaling pathways in hESCs using microfluidic technologies | 10 | | 40.04 | Defined, growth factor free production of cardiac cells and tissues from human pluripotent stem cells | 10 | | 40.05 | Human embryonic stem cell-derivatives in a hydrogel-based skin model | 10 |
| | Forum | 75.3 Making Collaborations Work| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 75.3.01 | \"Establishing a multibillion-dollar cell therapy industry requires a simple ABC approach - Academics, Businesspeople & Clinicians working together to integrate basic discovery, clinical translation and commercialization into a seamless process” | 0 | | 75.3.02 | Translational research in spinal cord injury: from molecule to man | 0 | | 75.3.03 | Utilising economies of scope to use the NHS as a cell therapy development and delivery partner | 0 | | 75.3.04 | Microstructure and chemistry affects the in vitro bioactivity of calcium phosphate bone graft substitutes | 0 | | 75.3.05 | Technological advances in graft manipulation and cellular therapies – removing the bottlenecks | 0 | | 75.3.06 | ApaTech as an example of how “academia/industry partnerships” can overcome barriers to commercialization of regenerative medicine products | 0 |
| | Rittersaal | 54 Controlled Drug Release| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 54.01 | Keynote: Controlled stem cell receptor activation using magnetic particle based approches | 15 | | 54.02 | Controlled delivery of rhBMP-2 from OPF hydrogel composites for bone tissue engineering | 10 | | 54.03 | FGF2 coacervate restores cardiac function | 10 | | 54.04 | Boosting osteogenic differentiation of MSCs by BMP-2 loaded silk fibroin nano particles | 10 | | 54.05 | The importance of proper protein handling and detection for the design of a BMP-2 release system | 10 | | 54.06 | Delivery and efficacy of interfering RNA via a crosslinked collagen hydrogel in an excisional in vivo model and a human pre-clinical model to reduce fibrosis | 10 |
| | Gartensaal | 14 A Novel Generation of Skin Substitutes to Clinically Treat Severe Skin Defects (in coop.EuroSkinGraft)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 14.01 | Keynote: A novel generation of skin substitutes to clinically treat severe skin defects | 15 | | 14.02 | Cultured keratinocytes for burn wound treatment; preliminary results of a prospective randomized controlled intra-patient comparative study | 7 | | 14.03 | The tissue engineering of human skin: Assembling an organ in vitro | 7 | | 14.04 | High density gene expression microarrays as a novel read-out tool in regenerative medicine | 7 | | 14.05 | Development of a novel collagen-based dermal regeneration scaffold (Novomaix); control of pore architecture | 7 | | 14.06 | Improving quality in non-commercial academic clinical research | 7 |
| | Geheime Ratstube | 09 Peripheral Nerve Repair| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 09.01 | Nerve guides using a 3-dimensionally structured chitosan core with an electrospun poly-caprolactone shell for peripheral nerve reconstruction | 10 | | 09.02 | End-to-side neurorrhaphy using an electrospun PCL/collagen nerve conduit for complex peripheral motor nerve regeneration | 10 | | 09.03 | Rescue of injured lumbar motorneurons after ventral root avulsion by grafted neuroectodermal stem cells | 10 | | 09.04 | Transitioning to a non-human primate nerve defect model for peripheral nerve repair | 10 | | 09.05 | Immune response to the acellular nerve xenograft laden with allogeneic adipose derived stem cells in rhesus monkey | 10 | | 09.06 | Outcomes with the use of human acellular nerve graft for repair of digital nerve defects: a prospective, multicenter, controlled clinical trial | 10 |
|
|
| 15:30 - 16:00 | Coffee Break |
| 16:00 - 17:30 | 6 Sessions| Room | Title |
|---|
| Festsaal | 15 Cardiac Regeneration| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| Cytoprotection, Nitic Oxide and Platelets in regenerative Medicine | 0 | | 15.01 | Keynote: Engineered heart tissue for myocardial regeneration | 15 | | 15.02 | Keynote: Engineered heart tissue to model human disease | 15 | | 15.04 | Ischemic preconditioning for cardiac tissue engineering with stem cells | 10 | | 15.05 | Design of synthetic patch for congenital heart defect repair using self-assembled polycaprolactone and gelatin-chitosan hydrogel | 10 |
| | Zeremoniensaal | 38 Developmental Biology and Tissue Engineering| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 38.01 | Keynote: Engineering of renal-like tissue using in vitro developmental models | 25 | | 38.02 | Formation of tissue structure by engineering epithelial progenitor cells of glandular organs by biomaterial cultivation | 10 | | 38.03 | Engineering MSC condensations: an example of skeletal developmental engineering | 10 | | 38.04 | Mechanical stimulation programs mesenchymal stem cells during valvulogenesis | 10 | | 38.05 | Tissue reconstruction potency of Oct4 expressing somatic cells | 10 |
| | Forum | 75.4 Translation Research of Advanced Therapies - Next Academia-Industry Partnership| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 75.4.01 | Production of cell therapies from clinical trial to commercial distribution | 0 | | 75.4.02 | An infection control solution for catheter exit sites: Translation from mice to device | 0 | | 75.4.03 | Financing regenerative medicine: Azellon Ltd, an asset centric business model working in public:private partnership | 0 | | 75.4.04 | Challenges in translational research: what role for SMEs? | 0 | | 75.4.05 | Cardiac derived cells for treatment of heart diseases - efforts to translate research into a marketable therapy | 0 | | 75.4.06 | Translation from research to GMP-compliant manufacturing: constructing a business model for a new stem cell source | 0 | | 75.4.07 | Early stage translational research of advanced therapies (part I) | 0 | | 75.4.08 | Early stage translational research of advanced therapies (part II) | 0 |
| | Rittersaal | 28 Silk Fibroin (and its Modifications)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 28.01 | Keynote: Fibroin: an example of hierarchy and conformation dominated biological behavior | 15 | | 28.02 | Keynote: Non-mulberry silk biopolymer as emerging natural biomaterials | 15 | | 28.03 | Repair of critical size cartilage defects in rat xiphoid using adipose-derived stem cells and silk fibroin 3D porous scaffolds | 10 | | 28.04 | Novel preparation of silk hydrogels under high pressure carbon dioxide | 10 | | 28.05 | Native silk for tissue engineering | 10 |
| | Gartensaal | 18 Pancreas Replacement & Liver Regeneration| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 18.01 | Keynote: Engineering an optimal implant for islet transplantation | 25 | | 18.02 | Therapeutic neo-islet engineering in subcutaneous site by islet sheet transplantation | 10 | | 18.03 | Coating Islets of Langerhans with cells improves sprout formation in vitro | 10 | | 18.04 | Novel oxygen generating biomaterial for enhancing cell survival under hypoxic conditions | 10 | | 18.05 | Micropatterned electrospun fibrous scaffolds for coculture of hepatocytes and fibroblasts | 10 |
| | Geheime Ratstube | 10 Axonal Regeneration and Repair in the Peripheral Nervous System| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 10.01 | Keynote: New concepts in peripheral nerve’s tissue engineering | 17 | | 10.02 | Keynote: New molecules and biohybrid templates to increase peripheral nerve regeneration | 17 | | 10.03 | Keynote: Novel approaches to accelerate axon elongation by growth factors | 12 | | 10.04 | Keynote: The influence of nanostructures on cellular processes during differentiation of neuronal stem cells | 12 | | 10.05 | Keynote: Extracorporeal shock wave treatment induces improved rate of functional recovery in the rat | 12 |
|
|
| 17:30 - 18:20 | Plenary Lecture (Festsaal)
Paradigm Shift: Evolution of tissue engineering strategies, Ivan Martin
Plenary Lecture (Festsaal)
Paradigm Shift: A high throughput toolbox for tissue engineering, Clemens van Blitterswijk |
| 18:20 - 19:00 | TERMIS EU Business Meeting (Festsaal)
SYIS Career Session: Experience abroad – A prerequisite for personal and professional development? |
| 19:30 | Austrian National Library: Gala Evening and Award Ceremony |
Sat, September 8, 2012
| Time | Activity |
|---|
| 08:30 - 10:00 | 6 Sessions| Room | Title |
|---|
| Festsaal | 61 3D Scaffold/Cell Printing| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 61.01 | Bioprinting anisotropic stem cell microenvironment | 10 | | 61.02 | Development and validation of an integrated organ printing system | 10 | | 61.03 | Monitoring analyte concentration using self reporting scaffolds a 3D culture model | 10 | | 61.04 | Laser fabrication of multi-scale elastic 3D scaffolds | 10 | | 61.05 | Self-assembly-based biofabrication | 10 | | 61.06 | Design, physical prototyping and initial characterization of “lockyballs”: enabling technological platform for bottom-up modular 3D tissue biofabrication | 10 |
| | Zeremoniensaal | 70 Translation in Tissue Engineering and Stem Cell Therapy (in coop. KOREA TERMS)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 70.01 | Keynote: Changing perspectives on translational research | 25 | | 70.02 | Keynote: Human articular cartilage repair using umbilical cord blood derived allogenic mesenchymal stem cells | 25 | | 70.03 | An efficient 3D microfibrous system for human pluripotent stem cell self-renewal and direct differentiation | 10 | | 70.04 | Electromagnetic fields (EMFs) can promote neuronal differentiation of human bone marrow-derived mesenchymal stem cells | 10 |
| | Forum | 37 Mechanotransduction in TERM| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 37.01 | Keynote: In situ mechanotransduction via vinculin regulates stem cell myogenesis | 15 | | 37.02 | Keynote: Differentiation and dynamic loading alter nuclear mechanics and mechanotransduction in mesenchymal stem cells | 15 | | 37.03 | Elasticity, recruited cell interactions and 3D tissue repair | 10 | | 37.04 | Stress-fiber remodeling in 3D: ‘contact guidance vs stretch avoidance’ | 10 | | 37.05 | Investigating mechanotransduction in 3D culture using different encapsulating hydrogel systems | 10 | | 37.06 | Mechano-transduction pathway interference with BMP-2 signaling cascade | 10 |
| | Rittersaal | 72 Cooperative Research - European Projects and Networks| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 72.02 | Four approaches to improve neuro implants | 15 | | 72.03 | EuroSTEC; Soft Tissue Engineering for Children | 15 |
| | Gartensaal | 11 Spinal Cord Injury - Neuroreconstruction of the Acutely and Chronically Injured Spinal Cord| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 11.01 | Keynote: Stem cells and biomaterials for the treatment of spinal cord injury | 15 | | 11.02 | Keynote: Biomaterials for cell transplantation and drug delivery after spinal cord injury | 15 | | 11.04 | Keynote: Bridging the spinal cord –a step towards functionalisation | 15 | | 11.05 | Altering secondary injury: How hydrogel scaffolds influence the inflammatory response in the spinal cord | 8 |
| | Geheime Ratstube | 05 Intradiscal Technologies and Spine Surgery (in coop. GRIBOI)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 05.01 | Keynote: MSC for disc regeneration: when and which way? | 15 | | 05.02 | Design of self-assembling peptide/glycosaminoglycan hydrogels for spinal therapies | 10 | | 05.03 | Inter-vertebral disc tissue engineering through design of injectable scaffolds and physiologically informed bioreactors | 10 | | 05.04 | Optimising microgel niches to influence adipose derived stem cells differentiation | 10 | | 05.05 | Covalent incorporation of bone morphogenetic protein-2 into fibrin-based hydrogels for intervertebral disc regeneration | 10 | | 05.06 | Assessment of an intradiscal injectable hydrogel stick | 10 |
|
|
| 10:00 - 10:30 | Coffee Break |
| 10:30 - 12:00 | 6 Sessions| Room | Title |
|---|
| Festsaal | 69 Clinical Aspects of Tissue Engineering| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 03.P18 | Development of a clinically feasible off-the-shelf bone tissue engineering strategy with the integrated use of human fetal mesenchymal stem cells, polycaprolactone scaffolds and a bi-axial rotating bioreactor | 15 | | 69.01 | Keynote: New materials-based strategies for regenerative medicine | 25 | | 69.03 | Retrospective analysis of patients with ulcers of (arterio-)venous, traumatic or decubitus origin treated with an autologous skin substitute | 15 | | 69.04 | A global assessment of stem cell engineering | 15 |
| | Zeremoniensaal | 56 TECHNOLOGIES - Automatization of bioreactor technologies for 3D tissue cultures| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 56.01 | Keynote: Bioreactor technology and automatization in the production of human 3D tissues | 30 | | 56.02 | Bioreactor systems for expansion and differentiation of human mesenchymal stem cells | 15 | | 56.03 | Assessment of the performance of a novel hydrostatic force bioreactor- changes of pH and oxygen tension during cell culture | 15 | | 56.04 | Increased flow velocity positively influences osteogenic differentiation of human stem cells in a perfusion bioreactor | 15 |
| | Forum | 13 Skin Regeneration| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 13.01 | Keynote: A versatile, biodegradable polyurethane scaffold for tissue repair and drug delivery | 15 | | 13.02 | Development of a vascularized skin construct using adipose derived stem cells from debrided burn skin | 10 | | 13.03 | Allogeneic living cell spray: a new concept in the treatment of wounds | 10 | | 13.04 | Skin tissue engineering in burns | 10 | | 13.05 | Development, validation and testing of a human tissue engineered hypertrophic scar model | 10 |
| | Rittersaal | 04 Hypertrophic Cartilage and Bone Tissue Engineering| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 04.01 | Keynote: Engineering hypertrophic cartilage grafts for bone repair via endchondral ossification | 15 | | 04.02 | Osteoclast-mediated activation of devitalized engineered cartilage to generate osteoinductive grafts | 10 | | 04.03 | Engineering a bone organ through endochondral ossification | 10 | | 04.04 | Channelled architectures accelerate in vivo mineralisation of engineered hypertrophic cartilaginous constructs | 10 | | 04.05 | Amniotic fluid MSC behaviour in bone microenviroment: Driving host reparative response | 10 | | 04.06 | MicroRNA-31 – a novel therapeutic target for bone regeneration and osteoporosis | 10 |
| | Gartensaal | 12 Spinal Cord injury (in coop. Wings of Life)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 12.01 | Keynote: A novel self-assembling peptide attenuates glial scarring and promotes neurological recovery following spinal cord injury | 15 | | 12.02 | Keynote: Combined treatments to repair the injured spinal cord | 15 | | 12.03 | Keynote: Axonal regeneration across cellular bridges in the lesioned spinal cord – challenges on the other side | 15 | | 12.04 | Keynote: CNS remyelination - can we wrap it up? Regulators of oligodendrocyte precursor cells in the process of myelin regeneration | 15 |
| | Geheime Ratstube | 34 Multi-scale and Hierarchical Scaffolds and Self Assembly Systems| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 34.01 | Keynote: Multi-scale scaffolds for tissue engineering | 15 | | 34.02 | Magnetic 3D assembly of microgels for tissue engineering and regenerative medicine | 10 | | 34.03 | Therapeutic effects of bioactive peptides on ischemic hind limb by recruiting mesenchymal stem cells | 10 | | 34.04 | Spontaneous co-assembly of molecularly designed building blocks into hierarchically ordered, dynamic, hybrid macrotubes | 10 | | 34.05 | Bioactive TGFbeta - CaP- alginate based scaffolds for osteochondral tissue repair: design, realization and multi-level characterization | 10 | | 34.06 | Method for creating nanofiber-reinforced hydrogel scaffolds by combination of electrospun nanofibers and hydrogels | 10 |
|
|
| 12:00 - 12:45 | Plenary Debate (Festsaal) - Future of publishing, Dietmar Hutmacher, David Williams |
| 12:45 - 13:15 | Lunch Break |
| 13:15 - 14:15 | Poster Session & Coffee & Cake |
| 14:15 - 15:45 | 6 Sessions| Room | Title |
|---|
| Festsaal | 68 Bench to Bedside Examples| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 68.02 | Lab to OR - the evolution of fibrin sealants in regenerative medicine and reconstructive surgery | 10 | | 68.03 | Versatility of the Dermal Regeneration Template (Integra®) engineered tissue in the reconstruction of different districts of the body | 10 | | 68.04 | Adipose stem cells and biomaterials for reconstruction of human bone defects | 10 | | 68.05 | Small molecule enhancer of BMP activities and inhibitor of osteoclast activity | 10 | | 68.06 | Stimulation of hair growth in humans by cell-secreted proteins | 10 |
| | Zeremoniensaal | 31 Bioinspiration and Biomimetics| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 31.01 | Keynote: Native chemical ligation and related reactions for polymer hydrogel cross-linking | 25 | | 31.02 | Functionalisation of methacrylated gellan gum hydrogels by anti-angiogenic dendrons | 10 | | 31.03 | Fibronectin matrix mimetics accelerate repair of chronic wounds | 10 | | 31.04 | Transfer printing of tissue with anisotropic extracellular matrix assembly by using cell interactive and thermosensitive hydrogels | 10 | | 31.05 | Sculpturing the complex lamellar architecture of annulus fibrosus tissue using chemically modified silk scaffold | 10 |
| | Forum | 07 Cartilage and Joints (ICRS)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 07.01 | Keynote: Biomaterials for autologous matrix-associated chondrocyte transplantation | 15 | | 07.02 | Tissue engineered nasal cartilage for the regeneration of articular cartilage in goats | 10 | | 07.03 | Ex vivo imaging and tracking of spion labelled mesenchymal stem cells and chondrocytes in orthopaedic cell based therapies | 10 | | 07.04 | Combining freshly isolated CD271+ positive infrapatellar fat pad stem cells and a TGF-β3 releasing scaffold to develop a single stage therapy for cartilage repair | 10 | | 07.05 | Biomaterial-based anti-angiogenic drug delivery system enhances the in vivo chondrogenesis of freshly seeded chondrocytes-based constructs | 10 | | 07.06 | Keynote: Biomechanics and mechanobiology of cartilage defect repair | 15 |
| | Rittersaal | 35 Surface Topography| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 35.01 | Keynote: Biomimetic surfaces exhibiting extreme wettability properties for tissue engineering applications | 25 | | 35.02 | MicroRNAs potentially regulate TGFβ/BMP & Wnt/Ca2+ signaling pathways on modified titanium implant surfaces leading to improved osteogenicity | 10 | | 35.03 | Human tenocyte response to nano-topographic interfaces and implications on medical device design | 10 | | 35.05 | Patterned superhydrophobic surfaces for the combinatorial assessment of 3D biomaterials-cells interactions | 10 | | 35.P12 | Multi-structured titania features for stem cell differentiation and osseointegration | 0 |
| | Gartensaal | 16 Heart Valve Generation| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 16.01 | Keynote: The role of textiles in cardiovascular tissue engineering | 15 | | 16.02 | Autologous CD133+ tissue-engineered pulmonary valved stent implantation: a percutaneous technique | 10 | | 16.03 | Modification of human pericardium based on dynamic loading, a new approach for heart valve tissue engineering | 10 | | 16.05 | Spatially selective cell embedding in fibrin based tissue engineered heart valves | 10 | | 16.06 | Valvular tissue formation and remodeling under physiological loads | 10 |
| | Geheime Ratstube | 19 Urogenital Tract| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 19.01 | Keynote: Amniotic derived cells for cell based therapies | 15 | | 19.02 | Keynote: Human endometrial mesenchymal stem cells and novel meshes as an autologous cell-based therapy for pelvic organ prolapse (POP) | 15 | | 19.03 | Keynote: Pre-establishment of a vascular network for urinary sphincter engineering | 15 | | 19.04 | Cell therapy for the treatment of neurogenic urinary incontinence (UI) in female nonhuman primates | 10 | | 19.05 | Repopulation of primary renal cells for whole organ engineering | 10 |
|
|
| 15:45 - 16:15 | Coffee Break |
| 16:15 - 17:45 | 6 Sessions| Room | Title |
|---|
| Festsaal | 22 Vascular Tissue Engineering (in coop. ESAO)| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 22.01 | Keynote: Challenges and outlook of vascular tissue engineering | 15 | | 22.02 | Keynote: New designs in electrospun vascular prosthetics | 15 | | 22.03 | Keynote: Compliant degradable electrospun nano-fibre structures for cardio vascular engineering | 15 | | 22.04 | Keynote: Acellular non-degradable nano-scaffolds | 15 | | 22.05 | Keynote: Differentiating between transanastomotic and trains-mural endothelialisation: the “isolation-loop-graft” model | 15 |
| | Zeremoniensaal | 55 TECHNOLOGIES - Bioreactors for Translational Research| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 55.01 | Keynote: Bioreactors for development of healthy and diseased myocardial tissue models | 15 | | 55.02 | Options for long-term monitoring strategies in bone tissue engineering | 10 | | 55.03 | Real-time and in-situ control of environmental parameters in a modular bioreactor | 10 | | 55.04 | All-in-one rapid-prototyped bioreactor/implant for semi-automated generation of tailor-made critical size bone tissue substitutes | 10 | | 55.05 | Capacitive stimulation enhanced osteogenic differentiation of primary human mesenchymal stem cells | 10 | | 55.06 | Engineering of human bone tissue from pluripotent stem cells in perfusion bioreactors | 10 |
| | Forum | 08 Cartilage and Joints-Cartilage Tissue Engineering| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 08.01 | Keynote: Cartilage engineering based on adult stem cells | 25 | | 08.02 | In vivo assessment of the regenerative potential of a novel multi-layer scaffold for osteochondral defect repair | 10 | | 08.03 | Cartilage repair in transplanted scaffold-free chondrocyte sheets using a minipig model | 10 | | 08.04 | VEGF blockade by soluble VEGF Receptor-2 induces in vivo chondrogenesis of human mesenchymal progenitor cells blockade by soluble vegf receptor-2 induces in vivo chondrogenesis of human mesenchymal progenitor cells | 10 | | 08.05 | Engineering of human ear shaped cartilage by co-culturing of human microtia chondrocytes with BMSCs | 10 |
| | Rittersaal | 62 Tissue Engineered Nutrition| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 62.01 | Framing in-vitro meat as art | 10 | | 62.02 | Skeletal myoblast differentiation on starch microspheres for the development of cultured meat | 10 | | 62.03 | Cultured meat by self-assembly | 10 | | 62.05 | Enabling technologies for scalable production of in vitro meat | 10 | | 62.06 | Tissue engineering of skeletal muscle and fat for meat production | 10 |
| | Gartensaal | 71 TE for In
Vitro Tests and Microfluidics| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 35.P03 | Tailoring the trajectory of cell rolling with cytotactic surfaces | 10 | | 57.P19 | Development of a 3D neuronal glial co-culture model for peripheral nerve studies and repair strategies | 10 | | 64.P07 | Fabrication of micro-tubular tissue structures using microfluidic gel formation system | 10 | | 71.01 | In-vivo like tissue fabrication to support efficient and cost-effective drug development | 10 | | 71.02 | Keynote: Monitoring type I allergic responses within a microfluidic 3D-co-culture system | 25 |
| | Geheime Ratstube | 21 Ocular Area| Abstract Book ID | Title | Speaking Time (minutes) |
|---|
| 21.01 | Keynote: Corneal tissue engineering for fundamental and clinical applications. | 15 | | 21.02 | A tissue-engineered plastic compressed collagen substrate suitable for human corneal endothelial layer transplantation | 10 | | 21.03 | In vivo evaluation of a biomimetic human cornea stroma model generated with cornea stem cells and biomaterials | 10 | | 21.04 | Keynote: Application of iPS cells for outer retinal reconstruction | 15 | | 21.05 | Keynote: RPE repair in eyes with retinal degeneration | 15 |
|
|
| 17:45 - 18:00 | Closing Remarks (Festsaal) |
